Clinical trial
Molecular Evaluation in Metastatic Breast Cancer - A Clinical Study of Accuracy and Response Assessment
NCT03358589 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Evaluation in Metastatic Breast Cancer - A Clinical Study of Accuracy and Response Assessment
- Lead sponsor
- Odense University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 1, 2017
- Completion date
- August 31, 2021
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic breast cancer, molecular imaging